These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17496399)

  • 1. Pathogenesis of focal and segmental glomerulosclerosis: a review.
    Akash N
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):226-30. PubMed ID: 17496399
    [No Abstract]   [Full Text] [Related]  

  • 2. Focal segmental glomerulosclerosis: recent advances.
    Pollak MR
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.
    Kerjaschki D
    J Clin Invest; 2001 Dec; 108(11):1583-7. PubMed ID: 11733553
    [No Abstract]   [Full Text] [Related]  

  • 5. [Focal segmental glomerulosclerosis: Pathogenesis, pathophysiology, and therapy].
    Hirayama K; Hagiwara M; Yamagata K; Koyama A
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():422-6. PubMed ID: 16523926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Membrane structures in 13 cases of focal segmental glomerulosclerosis].
    Tóth T
    Morphol Igazsagugyi Orv Sz; 1980 Oct; 20(4):245-9. PubMed ID: 7266520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocin-related mechanisms in posttransplant [corrected] recurrence of focal segmental glomerulosclerosis [corrected].
    Caridi G; Dagnino M; Sanna-Cherchi S; Perfumo F; Ghiggeri GM
    Transplant Proc; 2006 Dec; 38(10):3486-90. PubMed ID: 17175312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Focal and segmental glomerulosclerosis: clinical and histological aspects in 20 patients].
    Cisternas H; Rosenberg H; Vial S
    Rev Med Chil; 1986 Oct; 114(10):939-46. PubMed ID: 3575937
    [No Abstract]   [Full Text] [Related]  

  • 9. [Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].
    Schiffer M; Haller H
    Dtsch Med Wochenschr; 2006 Jul; 131(27):1541-5. PubMed ID: 16817104
    [No Abstract]   [Full Text] [Related]  

  • 10. Surprising results following conditional podocyte inactivation.
    Pollak MR
    J Am Soc Nephrol; 2009 Oct; 20(10):2086-8. PubMed ID: 19762489
    [No Abstract]   [Full Text] [Related]  

  • 11. [Morphological studies on focal glomerular sclerosis (FGS) in rat--disturbance of glomerular polyanion].
    Satoh H; Ishitobi F; Mizoguchi K; Takimoto T; Iidaka K
    Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):221-34. PubMed ID: 4021186
    [No Abstract]   [Full Text] [Related]  

  • 12. Late onset of familial nephrotic syndrome associated with a compound heterozygous mutation of the podocin-encoding gene.
    Ardiles LG; Carrasco AE; Carpio JD; Mezzano SA
    Nephrology (Carlton); 2005 Dec; 10(6):553-6. PubMed ID: 16354237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of focal segmental glomerulosclerosis.
    Woroniecki RP; Kopp JB
    Pediatr Nephrol; 2007 May; 22(5):638-44. PubMed ID: 17347836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive renal failure--inability of podocytes to replicate and the consequences for development of glomerulosclerosis.
    Kriz W
    Nephrol Dial Transplant; 1996 Sep; 11(9):1738-42. PubMed ID: 8918614
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis of nonimmune glomerulosclerosis: studies in animals and potential applications to humans.
    Striker GE; He CJ; Liu ZH; Yang DC; Zalups RK; Esposito C; Striker LJ
    Lab Invest; 1995 Nov; 73(5):596-605. PubMed ID: 7474933
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal models of FSGS: lessons for pathogenesis and treatment.
    Fogo AB
    Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocytes and the development of segmental glomerulosclerosis.
    Elger M; Kriz W
    Nephrol Dial Transplant; 1998 Jun; 13(6):1368-73. PubMed ID: 9641162
    [No Abstract]   [Full Text] [Related]  

  • 18. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
    Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(1):1-4. PubMed ID: 15772916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.
    Wetzels JF
    Am J Transplant; 2005 Oct; 5(10):2594; author reply 2595. PubMed ID: 16162217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.